Madrigal Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Good afternoon. I actually had to check the time. We are now in the afternoon. I hope everyone's enjoying day one of our healthcare conference. My name is Akash Tewari. I'm a pharma and biotech analyst here. I have the pleasure of hosting the Madrigal management team today.
I will -- before we get into Q&A on my end, I will hand it off to Paul and team to give some brief introductions and then we'll take it from there.
Thank you, Akash. We are Madrigal Pharmaceuticals. We have completed several Phase 3 studies with successful outcomes in nonalcoholic steatohepatitis and we are working diligently to file our NDA under Subpart H looking for accelerated approval. And we've guided to the end of this month to have filed the NDA. That's where we are, and we are anxious to get our document in.
Questions & Answers
Understood. So maybe let's start off with some of the remaining card
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
